In a recent study of temozolomide-resistant glioma cell colonies derived from a TMZ-exposed glioma cell line, the expression of stem cell markers such as CD133 and nestin was significantly higher in the newly formed tumor cells compared to their parent cells prior to TMZ exposure. Here, PROM1 is linked to central nervous system cancer.